Brief: Bioxytran Names Leslie Ajayi As Interim CMO, Head Of The Medical Advisory Board
31/07/2023 12:27
July 31 (Reuters) - Bioxytran Inc BIXT.PK :
* BIOXYTRAN NAMES LESLIE AJAYI AS INTERIM CMO AND HEAD OF
THE
MEDICAL ADVISORY BOARD
Source text for Eikon: ID:nGNX7KqbhL
Further company coverage: BIXT.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bioxytran
See all newsUS officials pressed China on rare earths, farm goods commitments, Bessent says (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst (updated)
Italy's Angelini Pharma completes $4.1 billion state-backed takeover of Catalyst
Brief: Bioxytran Inc Reports Positive Phase 1B/2A Clinical Study Results For Prolectin-M, Broad-Range Antiviral Drug In Mild To Moderate Covid-19
Brief: Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance With Prolectin-Mbioxytran